Novo Nordisk’s blockbuster diabetes drug Ozempic will be eligible for U.S. government’s price negotiations in less than a year based on current criteria, the Danish drugmaker’s CEO Lars Fruergaard …
Source link : http://www.bing.com/news/apiclick.aspx?ref=FexRss&aid=&tid=66f1edaa9d9a492688e6ea2afb45ed8a&url=https%3A%2F%2Fwww.msn.com%2Fen-us%2Fmoney%2Fmarkets%2Fnovo-says-ozempic-to-be-eligible-for-us-price-negotiations-in-less-than-a-year%2Far-AA1r4K1V&c=5571930317903803806&mkt=en-us
Author :
Publish date : 2024-09-23 11:18:00
Copyright for syndicated content belongs to the linked Source.